Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

236 ARTÍCULOS , VIENDO DEL 181 AL 195

The dystrophin-glycoprotein complex in brain development and disease

Waite A, Brown SC, Blake DJ.

Trends Neurosci. 2012 Aug;35(8):487-96. doi: 10.1016/j.tins.2012.04.004. Epub 2012 May 23.

Clinical spectrum of movement disorders after stroke in childhood and adulthood

Béjot Y, Giroud M, Moreau T, Benatru I.

Eur Neurol. 2012;68(1):59-64. doi: 10.1159/000336740. Epub 2012 Jun 22.

The representation of movement disorders in fictional literature

Voss H.

J Neurol Neurosurg Psychiatry. 2012 Oct;83(10):994-9. doi: 10.1136/jnnp-2012-302716. Epub 2012 Jun 29.

Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene

Gras D, Jonard L, Roze E, Chantot-Bastaraud S, Koht J, Motte J, Rodriguez D, Louha M, Caubel I, Kemlin I, Lion-François L, Goizet C, Guillot L, Moutard ML, Epaud R, Héron B, Charles P, Tallot M, Camuzat A, Durr A, Polak M, Devos D, Sanlaville D, Vuillaume I, Billette de Villemeur T, Vidailhet M, Doummar D.

J Neurol Neurosurg Psychiatry. 2012 Oct;83(10):956-62. doi: 10.1136/jnnp-2012-302505. Epub 2012 Jul 24.

Substance of abuse and movement disorders: complex interactions and comorbidities

Deik A, Saunders-Pullman R, Luciano MS.

Curr Drug Abuse Rev. 2012 Sep;5(3):243-53. doi: 10.2174/1874473711205030243.

Movement disorders and sleep

Driver-Dunckley ED, Adler CH.

Neurol Clin. 2012 Nov;30(4):1345-58. doi: 10.1016/j.ncl.2012.08.019.

Myoclonus and dystonia in cerebrotendinous xanthomatosis

Lagarde J, Roze E, Apartis E, Pothalil D, Sedel F, Couvert P, Vidailhet M, Degos B.

Mov Disord. 2012 Dec;27(14):1805-10. doi: 10.1002/mds.25206. Epub 2012 Oct 31.

Stereotypic Movements in Case of Sporadic Creutzfeldt-Jakob Disease: Possible Role of Anti-NMDA Receptor Antibodies

Molina M, Fekete R.

Case Rep Neurol. 2012 Sep;4(3):244-7. doi: 10.1159/000346298. Epub 2012 Dec 20.

Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome

Brunklaus A, Pohl K, Zuberi SM, de Sousa C.

Arch Dis Child. 2012 May;97(5):461-3. doi: 10.1136/adc.2010.204792. Epub 2011 Apr 3.

Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma

Morales La Madrid A, Rubin CM, Kohrman M, Pytel P, Cohn SL.

Pediatr Blood Cancer. 2012 Mar;58(3):472-4. doi: 10.1002/pbc.23131. Epub 2011 Apr 7.

Schinzel-Giedion syndrome: a further cause of early myoclonic encephalopathy and vacuolating myelinopathy

Watanabe S, Murayama A, Haginoya K, Tanaka S, Togashi N, Abukawa D, Sato A, Imaizumi M, Yoshikawa H, Takayama R, Wakusawa K, Kobayashi S, Sato I, Onuma A.

Brain Dev. 2012 Feb;34(2):151-5. doi: 10.1016/j.braindev.2011.03.010. Epub 2011 Apr 19.

Objective tinnitus from palatal myoclonus. Use of botulinum toxin: a case report

Conill Tobías N, de Paula Vernetta C, García Callejo FJ, Marco Algarra J.

Acta Otorrinolaringol Esp. 2012 Sep-Oct;63(5):391-2. doi: 10.1016/j.otorri.2011.02.004. Epub 2011 Apr 21.

Another promising treatment option for neuroblastoma-associated opsoclonus-myoclonus syndrome by oral high-dose dexamethasone pulse: lymphocyte markers as disease activity

Oguma M, Morimoto A, Takada A, Kashii Y, Fukuda T, Mori M, Yamagata T, Sugie H, Momoi MY.

Brain Dev. 2012 Mar;34(3):251-4. doi: 10.1016/j.braindev.2011.04.005. Epub 2011 Apr 29.

Ofatumumab for a rituximab-allergic child with chronic-relapsing paraneoplastic opsoclonus-myoclonus

Pranzatelli MR, Tate ED, Shenoy S, Travelstead AL.

Pediatr Blood Cancer. 2012 Jun;58(6):988-91. doi: 10.1002/pbc.23187. Epub 2011 May 25.

Worsening of negative myoclonus by lamotrigine in a case of idiopathic focal epilepsy of children with long-term follow-up

Gélisse P, Genton P, Velizarova R, Serafini A, Crespel A.

Brain Dev. 2012 Mar;34(3):248-50. doi: 10.1016/j.braindev.2011.05.001. Epub 2011 May 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias